צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים: Natera (NTRA)

Patent litigation and insurance risks have created volatility, as evidenced by the spike in the quarterly EPS change scale. Currently, the value of this parameter is 34.20. Growth is driven by breakthrough early cancer detection methods, although Natera, Inc. (NTRA) relies on external IT contractors and logistics providers. Innovations in bioinformatics are improving human health, offsetting pressure on sales margins.
NTRA (Natera): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Quarterly EPS growth measures the dynamics of net profit per share, reflecting the efficiency of capital generation. Investors utilize this rate to assess business sustainability and implement timely risk hedging. Analyzing this quarterly earnings per share growth chart reveals the impact of macroeconomic factors. For Natera, Inc. (NTRA), the positive trend is supported by the scaling of oncology tests, which has facilitated the transition to self-sufficiency and a stable cash flow.